ABVC BioPharma Inc
Research ABVC BioPharma Inc (ABVC) on Bullrun: market cap USD 25.77M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerABVC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 25.77M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 736.93K
- Free cash flow-USD 244.41K
Valuation Snapshot
latest market cap is USD 25.77M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 296.00K | -USD 7.91M | -USD 2.99M | 0.0% | -0.39 | USD 681.48K | USD 755.51K | USD 11.11M |
| FY2024 | USD 509.59K | -USD 4.90M | -USD 1.81M | 99.9% | -0.42 | USD 248.38K | USD 840.25K | USD 1.23M |
| FY2023 | USD 152.43K | -USD 7.79M | -USD 4.21M | -98.1% | -1.8 | USD 60.16K | USD 899.25K | USD 1.55M |
| FY2022 | USD 969.78K | -USD 16.42M | -USD 7.52M | 70.5% | -5.19 | USD 85.27K | USD 1.89M | USD 3.10M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 25.77M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 51.81M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 7.75M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 8.98M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 20.40M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 98.06M | n/a | n/a | n/a |
About ABVC BioPharma Inc
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ABVC BioPharma Inc's market cap?
ABVC BioPharma Inc's market capitalization is USD 25.77M.
What does ABVC BioPharma Inc do?
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.